Drug Patent Expirations in February 2008
 

The following drugs face patent expirations in February 2008

Applicant :: TRADENAME :: generic name

Merck :: FOSAMAX :: alendronate sodium
Merck :: FOSAMAX PLUS D :: alendronate sodium; cholecalciferol
Alcon :: CIPRO HC :: ciprofloxacin hydrochloride; hydrocortisone
Alcon :: CIPRODEX :: ciprofloxacin; dexamethasone
Pacira Pharms Inc :: DEPOCYT :: cytarabine
Gd Searle Llc :: INSPRA :: eplerenone
Pfizer Inc :: CAMPTOSAR :: irinotecan hydrochloride
Pharmos :: LOTEMAX :: loteprednol etabonate
Ge Healthcare :: TESLASCAN :: mangafodipir trisodium
Pacira Pharms Inc :: DEPODUR :: morphine sulfate

This list does not discriminate between dominant and non-dominant patents. Listed drugs above may be protected by additional patents and other regulatory protections.

For more details, visit DrugPatentWatch at http://www.DrugPatentWatch.com 

To subscribe to the free Patent Expiration Bulletin, visit http://www.DrugPatentWatch.com/newsletter 

Disclaimer:
All trademarks and applicant names are the property of their respective owners or licensors. Drug patent expiration data is presented "as is." Use of this information is at your own risk. No warranty is expressed or implied. There is no warranty that the drug patent expriation information is error free.

---
ABOUT DrugPatentWatch ( http://www.DrugPatentWatch.com )

DrugPatentWatch provides information on drug patent expirations. Complete details are provided for all FDA-approved small molecule drugs. Sales information is available for top-selling drugs. This value-added information supports the critical business functions of patent agents and attorneys, pharmaceutical companies, wholesalers, healthcare payers, and investors.